University of Tennessee Cancer Institute;Hem-Onc Consultants — Knoxville, Tennessee

University of Tennessee Cancer Institute;Hem-Onc Consultants is a clinical research site located in Knoxville, Tennessee, United States 37920.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Tennessee Cancer Institute;Hem-Onc Consultants has participated in 1 clinical trials.

Therapeutic areas: Metastatic Breast Cancer.

Sponsors: Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Tennessee Cancer Institute;Hem-Onc Consultants?

University of Tennessee Cancer Institute;Hem-Onc Consultants has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Tennessee Cancer Institute;Hem-Onc Consultants conducted?

University of Tennessee Cancer Institute;Hem-Onc Consultants has 1 clinical trials on record. Their work covers Metastatic Breast Cancer.

Is University of Tennessee Cancer Institute;Hem-Onc Consultants accredited by Crixeo Health?

University of Tennessee Cancer Institute;Hem-Onc Consultants has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Tennessee Cancer Institute;Hem-Onc Consultants?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.